Reason for request
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.
Clinical Benefit
| Insufficient |
In the current state of the dossier and while awaiting the results of the VEG 108844 non-inferiority study comparing VOTRIENT with sunitinib, the Transparency Committee considers that the actual benefit is insufficient to justify reimbursement by National Health Insurance. |
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
usPQMT3keHgGu4YE
